Xiaofei Cao Selected Research

Xiaofei Cao Research Topics

Disease

14	Neoplasms (Cancer) 11/2022 - 09/2014
4	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 09/2015
2	Obesity 01/2023 - 11/2019
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2022
2	Diabetes Complications 01/2020 - 01/2020
1	Fibrosis (Cirrhosis) 01/2024
1	Body Weight (Weight, Body) 01/2023
1	Schizophrenia (Dementia Praecox) 01/2023
1	Anhedonia 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Obstructive Sleep Apnea 01/2023
1	Mood Disorders (Mood Disorder) 01/2023
1	Snoring 01/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2022
1	Breast Neoplasms (Breast Cancer) 10/2022
1	Myotoxicity 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Strabismus (Squint) 01/2021
1	Postoperative Nausea and Vomiting (PONV) 01/2021
1	Cough 12/2020
1	Carcinogenesis 12/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Inflammation (Inflammations) 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Procedural Pain 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 09/2018
1	Cholangiocarcinoma 06/2018
1	Neuroblastoma 01/2017
1	Respiratory Insufficiency (Respiratory Failure) 01/2017
1	Esophageal Squamous Cell Carcinoma 04/2016
1	Retinoblastoma (Glioblastoma, Retinal) 09/2015
1	Prostatic Neoplasms (Prostate Cancer) 11/2014
1	Colonic Neoplasms (Colon Cancer) 09/2014

Drug/Important Bio-Agent (IBA)

4	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2024 - 12/2020
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2015
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2023 - 01/2020
2	EnzymesIBA 01/2023 - 11/2022
2	Circular RNAIBA 10/2022 - 01/2022
2	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 01/2022 - 01/2017
2	Fentanyl (Sublimaze)FDA LinkGeneric 12/2020 - 01/2017
2	Oxycodone (Oxycontin)FDA LinkGeneric 12/2020 - 01/2019
2	Thioctic Acid (Lipoic Acid)IBA 01/2020 - 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	BromidesIBA 11/2022
1	HexosaminesIBA 11/2022
1	Transaminases (Aminotransferases)IBA 11/2022
1	copineIBA 01/2022
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2022
1	GSK2256098IBA 01/2022
1	Local AnestheticsIBA 01/2022
1	penehyclidineIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Saline SolutionIBA 01/2021
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 12/2020
1	Carrier Proteins (Binding Protein)IBA 12/2020
1	salicylhydroxamic acid (SHAM)IBA 12/2020
1	LipopolysaccharidesIBA 01/2020
1	CaspasesIBA 01/2020
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 11/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2019
1	Remifentanil (Ultiva)FDA Link 01/2019
1	Serum AlbuminIBA 09/2018
1	ErbB Receptors (EGF Receptor)IBA 06/2018
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 06/2018
1	AfatinibIBA 06/2018
1	Progesterone FDA LinkGeneric 01/2017
1	Procaine (Novocaine)FDA LinkGeneric 01/2017
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2017
1	LipidsIBA 01/2017
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2017
1	AmidesIBA 01/2017
1	Opioid Analgesics (Opioids)IBA 01/2017
1	Tetracaine (Amethocaine)FDA LinkGeneric 01/2017
1	Complement System Proteins (Complement)IBA 04/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2016
1	Immunoglobulin G (IgG)IBA 04/2016
1	Interleukin-17 (Interleukin 17)IBA 04/2016
1	SurvivinIBA 09/2015
1	sepantroniumIBA 09/2015
1	Homeobox A10 ProteinsIBA 11/2014
1	Phosphotransferases (Kinase)IBA 09/2014
1	TOR Serine-Threonine KinasesIBA 09/2014
1	Biomarkers (Surrogate Marker)IBA 09/2014

Therapy/Procedure

3	Anesthesia 01/2023 - 01/2019
3	Therapeutics 11/2022 - 01/2019
2	Immunotherapy 01/2022 - 04/2016
1	General Anesthesia 01/2021
1	Intravenous Administration 12/2020
1	Radiofrequency Ablation 01/2019
1	Intravenous Injections 01/2019
1	Length of Stay 09/2018